Trials / Not Yet Recruiting
Not Yet RecruitingNCT07175324
Oct-A and Perimetry in Multiple Sclerosis
Correlation Between Optical Coherence Tomography Angiography and Visual Field Changes in Patients With Multiple Sclerosis
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 32 (estimated)
- Sponsor
- Assiut University · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Accepted
Summary
This study aims to assess retinal vascular density using OCT-A and correlate these parameters with visual field changes in MS patients with and without a history of ON
Detailed description
The aim of this work is to investigate the correlation between visual field parameters and optical coherence tomography angiography (OCT-A) findings in patients with multiple sclerosis (MS). MS is a chronic autoimmune demyelinating disease that frequently involves the visual pathway, often presenting with optic neuritis (ON) and subsequent neurodegeneration. OCT-A, a non-invasive imaging modality, enables detailed visualization and quantification of retinal microvasculature, particularly the superficial and deep capillary plexuses, which supply the retinal ganglion cells and nerve fiber layers. Previous studies have demonstrated reduced retinal vessel density and thinning of retinal nerve fiber layer (RNFL) and ganglion cell complex (GCC) in MS patients, reflecting neuro-axonal damage and microvascular impairment. However, the relationship between these structural and vascular changes and functional visual outcomes, such as visual field loss, remains to be fully elucidated. This study aims to assess retinal vascular density using OCT-A and correlate these parameters with visual field indices in MS patients with and without a history of ON. By analyzing inter-eye differences and comparing with MS patients, the research seeks to clarify whether OCT-A metrics can serve as reliable biomarkers for visual dysfunction and disease progression in MS. Understanding this correlation could improve early detection of neuroretinal damage, guide monitoring of disease activity, and potentially inform therapeutic strategies.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | optical coherence tomography angiography | correlation between OctA and Visual field changes in Multiple Sclerosis |
| DEVICE | Visual Field Perimetry | Correlation between OctA and Visual field changes in Multiple sclerosis |
Timeline
- Start date
- 2025-09-01
- Primary completion
- 2026-09-01
- Completion
- 2026-10-01
- First posted
- 2025-09-16
- Last updated
- 2025-09-16
Source: ClinicalTrials.gov record NCT07175324. Inclusion in this directory is not an endorsement.